Medicare Enrolled

Dr. Amir Kashani, MD, MS

Cardiovascular Disease · Houston, TX
Practice pattern: Remote & Electrophysiology— Practice combining remote and electrophysiology services
Speaking/Promotional
10496 KATY FWY STE 130, Houston, TX 77043
7134642928
In practice since 2008 (17 years)
NPI: 1790938538 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kashani from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kashani? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kashani

Dr. Amir Kashani is a cardiovascular disease in Houston, TX, with 17 years in practice. Based on federal Medicare data, Dr. Kashani performed 7,386 Medicare services across 4,308 unique beneficiaries.

Between the years covered by Open Payments, Dr. Kashani received a total of $157,094 from 36 pharmaceutical and/or device companies across 442 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kashani is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice▲ Top 7% volume in TX$ $157,094 industry payments

Medicare Practice Summary

Medicare Utilization ↗
7,386
Medicare services
Top 7% in TX for cardiovascular disease
4,308
Unique beneficiaries
$132
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~434 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Regadenoson injection (Lexiscan) for heart stress test816$43$221
Office visit, established patient (30-39 min)760$97$183
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec610$28$150
Remote pacemaker/defibrillator monitoring, 90 days608$17$60
Electrocardiogram (EKG), 12-lead582$11$80
Office visit, established patient (20-29 min)479$65$122
Evaluation of cardiac rhythm monitor system, remote up to 30 days360$20$50
Remote pacemaker monitoring, 90 days310$22$65
Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days300$28$155
Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days277$19$150
Echocardiogram, transthoracic252$146$800
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician212$57$400
Hospital follow-up visit, moderate complexity203$63$276
Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries202$425$547
Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan198$1,943$7,309
Nuclear medicine study of heart muscle blood flow by pet197$147$487
Programming of dual lead pacemaker system111$58$167
New patient office visit (45-59 min)85$122$283
Initial hospital admission, moderate complexity82$106$360
Programming of multiple lead implantable defibrillator system80$79$279
EKG interpretation and report70$7$60
Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes63$10$132
Repair of left upper heart chamber with implant with review by radiologist62$622$3,000
Programming of dual lead implantable defibrillator system59$74$143
Office visit, established patient, complex (40-54 min)49$130$248
Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional45$680$1,846
Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional44$21$67
Ultrasound of both sides of head and neck blood flow41$127$368
New patient office visit (30-44 min)38$72$186
Ultrasound study of arm or leg veins with compression and maneuvers37$113$353
Ultrasound study of one arm or leg veins with compression and maneuvers32$82$256
Ultrasound of leg arteries or artery grafts23$156$665
Insertion of heart rhythm monitor under skin18$3,533$8,000
Programming of multiple lead pacemaker system16$67$127
Hospital follow-up visit, high complexity15$97$322
Insertion of pacemaker and upper and lower heart chamber electrode14$420$1,600
Telephone medical discussion with physician, 21-30 minutes14$86$246
Insertion of left lower heart electrode for pacemaker or defibrillator11$376$1,000
Removal and replacement of dual lead permanent pacemaker11$282$890
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
24.0% high complexity
21.1% medium
54.9% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$157,094
Total received (2018-2024)
Avg $22,442/year across 7 years
Top 3% in TX for cardiovascular disease
36
Companies
442
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$92,740 (59.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$57,311 (36.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,043 (4.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$14,395
2023
$12,857
2022
$33,614
2021
$11,537
2020
$12,663
2019
$50,108
2018
$21,920

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$101,721
BOSTON SCIENTIFIC CORPORATION
$31,702
Abbott Laboratories
$19,211
Medtronic, Inc.
$1,031
Medtronic Vascular, Inc.
$490
Impulse Dynamics (USA) Inc.
$438
ABIOMED
$432
BIOTRONIK INC.
$321
Biocompatibles, Inc.
$299
Janssen Pharmaceuticals, Inc
$223
E.R. Squibb & Sons, L.L.C.
$183
Novartis Pharmaceuticals Corporation
$166
Takeda Pharmaceuticals U.S.A., Inc.
$102
Merck Sharp & Dohme LLC
$94
Amgen Inc.
$90
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$53
LANTHEUS MEDICAL IMAGING, INC.
$46
Aziyo Biologics, Inc.
$44
CARDIVA MEDICAL, INC.
$43
Tactile Systems Technology Inc
$43
Bard Peripheral Vascular, Inc.
$42
Novo Nordisk Inc
$38
BRACCO DIAGNOSTICS INC.
$38
Lantheus Medical Imaging, Inc.
$29
PFIZER INC.
$27
Venclose Inc.
$24
Esperion Therapeutics, Inc.
$19
Boehringer Ingelheim Pharmaceuticals, Inc.
$19
AstraZeneca Pharmaceuticals LP
$19
Kiniksa Pharmaceuticals International, plc
$18
Shockwave Medical, Inc
$17
Amarin Pharma Inc.
$16
ARBOR PHARMACEUTICALS, INC.
$15
Chiesi USA, Inc.
$14
Regeneron Healthcare Solutions, Inc.
$12
Preventice Services, LLC
$12
Top 3 companies account for 97.2% of total payments
Associated products mentioned in payments ›
AMPLATZER · AMPLATZER AMULET · AMPLATZER Occluders · AMPLATZER TORQVUE 45 X 45 · AMPLATZER TorqVue Delivery Systm · AMPLATZER Vascular Plug and Accs · AMPLATZER Vascular Plugs · ASSURITY · ATTAIN COMMAND + SUREVALVE · AZURE XT DR MRI SURESCAN · Allure CRT Pacemaker · Amplia MRI · Arcalyst · Assurity Pacemaker · Astron; Pulsar; AstronPulsar · Azure · BG Mini Plus · CAMZYOS · CARDIOMEMS · CARDIVA VASCADE 5F VCS · CARDIVA VASCADE 6/7F VCS · CHANTIX · CLEVIPREX · COMPIA MRI QUAD CRT-D SURESCAN · CONFIRM RX · CROME DR MRI SURESCAN · CRT-Ds · CardioMEMS HF System · Cardiogen-82 · CareLink · ClosureFast · Compia MRI · Confirm Rx · DEFINITY · ECM Patch · ELIQUIS · EMBLEM SICD ELECTRODE DELIVERY SYSTEM · ENTRESTO · ESSENTIO · EVERA MRI XT DR SURESCAN · EVRSF · Edarbyclor · Entyvio · FARXIGA · FLEXITOUCH · GALLANT · GENERAL THERAPIES · GENERAL VASCULAR INTERVENTION · GENERAL THERAPIES · General - Therapies · General - Vascular Intervention · HeartMate 3 Left Ventricular Assist Device · INOGEN · Impella · JARDIANCE · JETSTREAM · LATITUDE Communicator Power Supply · LEQVIO · LINQ II · LUX-Dx Insertable Cardiac Monitor · LifeVest · MICRA · MITRACLIP · MYCARELINK · Merlin Connectivity and Remote · Micra · NEXLETOL · ONYX FRONTIER · OPTIMIZER · Occluders · Optimizer · Orsiro · Ozempic · PRALUENT · Pouch · Quadra Assura CRT Defibrillator · RELIANCE 4FRONT · RESONATE · Repatha · Resolute · Reveal LINQ · SELECTSECURE · SELECTSITE · SITUATE · STERLING · SYNERGY · THERAPIES · VARITHENA · VENASEAL · VERQUVO · VIGILANT · Varithena Administration Pack · Vascepa · Vascular Lithotripsy · VenaSeal · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · Watchman · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (59%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for cardiovascular disease in TX.

Equivalent to $2,127 per 100 Medicare services performed
Looking for a cardiovascular disease in Houston?
Compare cardiovascular diseases in the Houston area by procedure volume, costs, and industry payment transparency.
Browse cardiovascular diseases nearby

Geographic Context

Cardiovascular Diseases within 10 mi
376
Per 100K population
7.9
County median income
$73,104
Nearest hospital
HOUSTON BEHAVIORAL HEALTHCARE HOSPITAL LLC
3.8 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Kashani is a remote & electrophysiology specialist, with above-average Medicare volume (top 7% in TX), and high industry engagement (speaking/promotional, top 3%), with 17 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Kashani experienced with regadenoson injection (lexiscan) for heart stress test?
Based on Medicare claims data, Dr. Kashani performed 816 regadenoson injection (lexiscan) for heart stress test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kashani receive payments from pharmaceutical companies?
Yes. Dr. Kashani received a total of $157,094 from 36 companies across 442 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kashani's costs compare to other cardiovascular diseases in Houston?
Dr. Kashani's average Medicare payment per service is $132. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kashani) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →